{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T22:11:41Z","timestamp":1758924701227,"version":"3.37.3"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060149"],"award-info":[{"award-number":["82060149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Polyglutamine diseases are degenerative diseases in the central nervous\nsystem caused by CAG trinucleotide repeat expansion which encodes polyglutamine tracts, leading\nto the misfolding of pathological proteins. Small peptides can be designed to prevent polyglutamine\ndiseases by inhibiting the polyglutamine protein aggregation, for example, polyglutamine\nbinding peptide 1(QBP1). However, the transportation capability of polyglutamine binding peptide\n1 across the blood-brain barrier is less efficient. We hypothesized whether its therapeutic effect\ncould be improved by increasing the rate of membrane penetration.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>The objective of the study was to explore whether polyglutamine binding peptide 1 conjugated\ncell-penetrating peptides could pass through the blood-brain barrier and inhibit the aggregation\nof polyglutamine proteins.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In order to investigate the toxic effects, we constructed a novel stable inducible PC12\ncells to express Huntington protein that either has 11 glutamine repeats or 63 glutamine repeats to\nmimic wild type and polyglutamine expand Huntington protein, respectively. Both SynB3 and\nTAT conjugated polyglutamine binding peptide 1 was synthesized, respectively. We tested their capabilities\nto pass through a Trans-well system and subsequently studied the counteractive effects\non polyglutamine protein aggregation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The conjugation of cell-penetrating peptides to SynB3 and TAT enhanced the transportation\nof polyglutamine binding peptide 1 across the mono-cell layer and ameliorated polyglutamine--\nexpanded Huntington protein aggregation; moreover, SynB3 showed better delivery efficiency\nthan TAT. Interestingly, it has been observed that polyglutamine binding peptide 1 specifically inhibited\npolyglutamine-expanded protein aggregation rather than affected other amyloidosis proteins,\nfor example, \u03b2-Amyloid.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our study indicated that SynB3 could be an effective carrier for polyglutamine binding\npeptide 1 distribution through the blood-brain barrier model and ameliorate the formation of polyglutamine\ninclusions; thus SynB3 conjugated polyglutamine binding peptide 1 could be considered\nas a therapeutic candidate for polyglutamine diseases.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929866529666211221163930","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T14:42:23Z","timestamp":1640270543000},"page":"110-120","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["SynB3 Conjugated QBP1 Passes Blood-Brain Barrier Models and Inhibits PolyQ Protein Aggregation"],"prefix":"10.2174","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8864-0867","authenticated-orcid":true,"given":"Lingyan","family":"Zuo","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Dali University, Dali, China | Institute of Translational Medicine for Metabolic Diseases, Dali University, Dali, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqian","family":"Li","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Dali University, Dali, China | Institute of Translational Medicine for Metabolic Diseases, Dali University, Dali, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jifang","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Affiliated Hospital of Dali University, Dali, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingzhen","family":"Su","sequence":"additional","affiliation":[{"name":"Medical School, Kunming University, Kunming, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Shuai","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Dali University, Dali, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine for Metabolic\nDiseases, Dali University, Dali, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/199229","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/199229\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/199229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T14:22:21Z","timestamp":1646835741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/199229\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929866529666211221163930","relation":{},"ISSN":["0929-8665"],"issn-type":[{"type":"print","value":"0929-8665"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-06-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}